Skip to main navigation Skip to search Skip to main content

Hypoxia imaging for treatment planing with the novel radiopharmaceutical 18F-fluoroazomycinarabinoside (FAZA) in cervical cancer-a pilot study.

  • M. Schütz
  • , S. Kommata
  • , Peter Angelberger
  • , R. Schön
  • , Robert Dudczak
  • , Kurt Kletter
  • , B. Bachtiary
  • , G. Karanikas
  • Medical University of Vienna

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Number of pages1
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume34
Issue number2
Publication statusPublished - 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Field

  • Biosensor Technologies

Cite this